10^th Plasma Product Biotechnology 2017

Join us at the 10^th Plasma Product Biotechnology conference, at the Radisson Blu Resort.

Learn about our latest developments to overcome IgG purification and regulatory bottlenecks.

Immunoglobulin (IgG) is known to be the driver of the plasma industry and manufacturers are facing increasing pressures to provide safe, efficacious and secure supply of these therapeutics.

In addition, the switch to subcutaneous administration as well as increasing regulatory requirements on isoagglutinin have led to major improvements in patients’ lives.

The presentations will describe our latest innovations in the production of subcutaneous IgG formulations and the removal of isoagglutinin. We look forward to seeing you.

Visit the Event Website

Our Presentations

Tuesday, May 16 - 12:00 - 12:30

High Viscosity Tangential Flow Filtration (TFF) Applications in IgG

Craig Jackson et al, EMD Millipore Corporation, Bedford, MA, USA

Thursday, May 18 - 16:00 - 16:30

Eshmuno® P Anti-A and Anti-B: Affinity Resins for Removal of Anti-A and Anti-B Isoagglutinin

Santosh B. Rahane et al, EMD Millipore Corporation, Bedford, MA, USA